Clinical Trial Update: Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine

View source ↗

Summary

This completed clinical trial assesses how immunosuppression in inflammatory bowel disease patients affects their antibody response to the influenza vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Snippet

Sponsor: Boston Children's Hospital | Conditions: Inflammatory Bowel Disease (IBD), Immunosuppressed or Non-Immunosuppressed | Status: COMPLETED